Transform Your Future: Ace the 2026 Certified Diabetes Educator Exam!

The selection of the second option highlights the key advantages of SGLT2 inhibitors, which play a significant role in managing type 2 diabetes. These medications primarily function by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine. This mechanism results in a reduction of blood glucose levels, while also contributing to weight loss since excess glucose is being removed from the body rather than stored.

Moreover, studies have shown that SGLT2 inhibitors help lower blood pressure. This can be particularly beneficial for individuals with type 2 diabetes, who often face comorbid conditions such as hypertension. Another vital aspect is their low risk of causing hypoglycemia. Unlike some other diabetes medications that can lead to dangerously low blood sugar levels, SGLT2 inhibitors reduce blood glucose without significant risk of hypoglycemic episodes, thereby offering a safer option for glucose management.

The other choices do not accurately reflect the benefits associated with SGLT2 inhibitors. For instance, the first option contradicts the main effects of these medications, as they are not associated with an increase in blood glucose levels or weight. The third option incorrectly implies that SGLT2 inhibitors primarily enhance insulin sensitivity instead of their primary action related to renal glucose handling